Host: Matt Birnholz, MD

Guest: Everett E. Vokes, MD

Dr. Birnholz and Dr. Vokes will be discussing some of the exciting new data presented at ASCO 2016 on the management of non-small cell lung cancer. Since the recording of this interview, pembrolizumab was approved by the FDA on October 24, 2016 for use in Non-small Cell Lung Cancer.